330 related articles for article (PubMed ID: 26981525)
21. Exercise during pregnancy decreases doxorubicin-induced cardiotoxic effects on neonatal hearts.
Brito VB; Nascimento LV; Nunes RB; Moura DJ; Lago PD; Saffi J
Toxicology; 2016 Aug; 368-369():46-57. PubMed ID: 27565713
[TBL] [Abstract][Full Text] [Related]
22. Apigenin attenuates doxorubicin induced cardiotoxicity via reducing oxidative stress and apoptosis in male rats.
Zare MFR; Rakhshan K; Aboutaleb N; Nikbakht F; Naderi N; Bakhshesh M; Azizi Y
Life Sci; 2019 Sep; 232():116623. PubMed ID: 31279781
[TBL] [Abstract][Full Text] [Related]
23. M
Liu X; Li P; Huang Y; Li H; Liu X; Du Y; Lin X; Chen D; Liu H; Zhou Y
Redox Biol; 2024 Feb; 69():102993. PubMed ID: 38104484
[TBL] [Abstract][Full Text] [Related]
24. Doxorubicin induces cardiomyocyte apoptosis and atrophy through cyclin-dependent kinase 2-mediated activation of forkhead box O1.
Xia P; Chen J; Liu Y; Fletcher M; Jensen BC; Cheng Z
J Biol Chem; 2020 Mar; 295(13):4265-4276. PubMed ID: 32075913
[TBL] [Abstract][Full Text] [Related]
25. MiR-21 Protected Cardiomyocytes against Doxorubicin-Induced Apoptosis by Targeting BTG2.
Tong Z; Jiang B; Wu Y; Liu Y; Li Y; Gao M; Jiang Y; Lv Q; Xiao X
Int J Mol Sci; 2015 Jun; 16(7):14511-25. PubMed ID: 26132560
[TBL] [Abstract][Full Text] [Related]
26. GCN2 deficiency ameliorates doxorubicin-induced cardiotoxicity by decreasing cardiomyocyte apoptosis and myocardial oxidative stress.
Wang Y; Lei T; Yuan J; Wu Y; Shen X; Gao J; Feng W; Lu Z
Redox Biol; 2018 Jul; 17():25-34. PubMed ID: 29660505
[TBL] [Abstract][Full Text] [Related]
27. Paradoxically, iron overload does not potentiate doxorubicin-induced cardiotoxicity in vitro in cardiomyocytes and in vivo in mice.
Guenancia C; Li N; Hachet O; Rigal E; Cottin Y; Dutartre P; Rochette L; Vergely C
Toxicol Appl Pharmacol; 2015 Apr; 284(2):152-62. PubMed ID: 25711856
[TBL] [Abstract][Full Text] [Related]
28. Mode of treatment governs curcumin response on doxorubicin-induced toxicity in cardiomyoblasts.
Jain A; Rani V
Mol Cell Biochem; 2018 May; 442(1-2):81-96. PubMed ID: 28929270
[TBL] [Abstract][Full Text] [Related]
29. Ghrelin inhibits doxorubicin cardiotoxicity by inhibiting excessive autophagy through AMPK and p38-MAPK.
Wang X; Wang XL; Chen HL; Wu D; Chen JX; Wang XX; Li RL; He JH; Mo L; Cen X; Wei YQ; Jiang W
Biochem Pharmacol; 2014 Apr; 88(3):334-50. PubMed ID: 24522112
[TBL] [Abstract][Full Text] [Related]
30. Protective effect of naringenin-7-O-glucoside against oxidative stress induced by doxorubicin in H9c2 cardiomyocytes.
Han XZ; Gao S; Cheng YN; Sun YZ; Liu W; Tang LL; Ren DM
Biosci Trends; 2012 Feb; 6(1):19-25. PubMed ID: 22426099
[TBL] [Abstract][Full Text] [Related]
31. Cytoprotective Effect of Vitamin D on Doxorubicin-Induced Cardiac Toxicity in Triple Negative Breast Cancer.
Lee KJ; Wright G; Bryant H; Wiggins LA; Dal Zotto VL; Schuler M; Malozzi C; Cohen MV; Gassman NR
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299059
[TBL] [Abstract][Full Text] [Related]
32. Doxorubicin-induced cardiomyocyte apoptosis: Role of mitofusin 2.
Tang H; Tao A; Song J; Liu Q; Wang H; Rui T
Int J Biochem Cell Biol; 2017 Jul; 88():55-59. PubMed ID: 28483668
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of Carbonyl Reductase 1 Safely Improves the Efficacy of Doxorubicin in Breast Cancer Treatment.
Jo A; Choi TG; Jo YH; Jyothi KR; Nguyen MN; Kim JH; Lim S; Shahid M; Akter S; Lee S; Lee KH; Kim W; Cho H; Lee J; Shokat KM; Yoon KS; Kang I; Ha J; Kim SS
Antioxid Redox Signal; 2017 Jan; 26(2):70-83. PubMed ID: 27357096
[TBL] [Abstract][Full Text] [Related]
34. A herbal formula, SYKT, reverses doxorubicin‑induced myelosuppression and cardiotoxicity by inhibiting ROS‑mediated apoptosis.
Chen T; Shen HM; Deng ZY; Yang ZZ; Zhao RL; Wang L; Feng ZP; Liu C; Li WH; Liu ZJ
Mol Med Rep; 2017 Apr; 15(4):2057-2066. PubMed ID: 28260045
[TBL] [Abstract][Full Text] [Related]
35. miR-451 Silencing Inhibited Doxorubicin Exposure-Induced Cardiotoxicity in Mice.
Li J; Wan W; Chen T; Tong S; Jiang X; Liu W
Biomed Res Int; 2019; 2019():1528278. PubMed ID: 31355248
[TBL] [Abstract][Full Text] [Related]
36. Rac1 signalling mediates doxorubicin-induced cardiotoxicity through both reactive oxygen species-dependent and -independent pathways.
Ma J; Wang Y; Zheng D; Wei M; Xu H; Peng T
Cardiovasc Res; 2013 Jan; 97(1):77-87. PubMed ID: 23027656
[TBL] [Abstract][Full Text] [Related]
37. Combinatorial resveratrol and quercetin polymeric micelles mitigate doxorubicin induced cardiotoxicity in vitro and in vivo.
Cote B; Carlson LJ; Rao DA; Alani AWG
J Control Release; 2015 Sep; 213():128-133. PubMed ID: 26160305
[TBL] [Abstract][Full Text] [Related]
38. Nucleolin protects against doxorubicin-induced cardiotoxicity via upregulating microRNA-21.
Sun H; Tong Z; Fang Y; Jiang B; Liang P; Tang Y; Li Y; Wu Y; Xiao X
J Cell Physiol; 2018 Dec; 233(12):9516-9525. PubMed ID: 29968904
[TBL] [Abstract][Full Text] [Related]
39. CO and bilirubin inhibit doxorubicin-induced cardiac cell death.
Kim DS; Chae SW; Kim HR; Chae HJ
Immunopharmacol Immunotoxicol; 2009; 31(1):64-70. PubMed ID: 18756386
[TBL] [Abstract][Full Text] [Related]
40. Ovatodiolide sensitizes aggressive breast cancer cells to doxorubicin, eliminates their cancer stem cell-like phenotype, and reduces doxorubicin-associated toxicity.
Bamodu OA; Huang WC; Tzeng DT; Wu A; Wang LS; Yeh CT; Chao TY
Cancer Lett; 2015 Aug; 364(2):125-34. PubMed ID: 25976769
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
